Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Viatris Reaches $264m EpiPen Settlement Agreement With Trial Imminent
Company Admits No Wrongdoing; Maintains ‘That It Acted Lawfully’
Mar 02 2022
•
By
Dean Rudge
Viatris' settlement must be ratified by the court • Source: Shutterstock: Chris Bain
More from Deals
More from Business
